FDA Inspection
Taisho Pharmaceutical Co., Ltd.Taisho Pharmaceutical Co., Ltd. – FDA Inspection, Mar 29, 2019
Record Details
This FDA Inspection record concerns Taisho Pharmaceutical Co., Ltd., with an inspection on March 29, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · e275948c-3022-4694-b50c-d1883d341100
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1087840
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Taisho Pharmaceutical Co., Ltd.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 27, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Taisho Pharmaceutical Co., Ltd.
- FDA Inspection 951450 - 2015-11-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.